What is the NVO stock price prediction for next 2 weeks?

According to our price prediction algorithm,Novo Nordisk A/S (NVO) price will be around $34.93 in the next 2 weeks. This means it will decrease by -5.540500338066262 from the last closing price. This prediction may vary from other time period filters for NVO stock.

What can be the highest Possible price of NVO stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, NVO can achieve the highest price of $37.22 which is 0.6502555138131383 higher than last closing price. This prediction may vary from other time period filters for NVO stock.

What can be the lowest Possible price of NVO stock in next 2 weeks?

As per the forecast and algorithmic analysis, NVO stock price can be as low as $32.42 which is -12.32024549060227 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for NVO stock.

Will NVO stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that NVO stock will lose-5.540500338066262 in the next 2 weeks. This prediction may vary from other time period filters for NVO stock.

What is NVO stock last closing price?

Last closing price of NVO stock was $36.98.

What is NVO stock price prediction?

NVO stock price prediction means predicting the future closing prices of NVO stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of NVO stock in a certain time period.

How we predict NVO stock future prices?

If you are searching for NVO stock forecast, analysis or price prediction, then you might be wondering what Novo Nordisk A/S (NVO) will do in the future. Our NVO price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This NVO price prediction will likely answer most of your questions.

How frequent we update NVO stock predictions?

We are updating the forecasts for the NVO stock on daily basis.

Is using ML forecasting for NVO stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for NVO stock same for all the time periods?

No, the prediction for NVO stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Novo Nordisk A/S Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$36.981.23%Since 2 Weeks

Predicted Price$34.93-5.54%For 2 Weeks

Upper Predicted Price$37.220.65%For 2 Weeks

Lower Predicted Price$32.42-12.32%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of NVO will decline by -5.54% over the next 2 Weeks and hit $34.93 by Thursday, April 16, 2026. In that time frame, NVO's share price is expected to range between $32.42 and $37.22.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 16, 2026	32.93	35.26	37.65
Apr 15, 2026	33.05	35.45	37.90
Apr 14, 2026	32.90	35.26	37.68
Apr 13, 2026	32.67	34.90	37.38
Apr 10, 2026	33.51	36.00	38.26
Apr 9, 2026	33.91	36.12	38.52
Apr 8, 2026	34.17	36.31	38.68
Apr 7, 2026	34.05	36.12	38.45
Apr 6, 2026	33.49	35.76	37.87
Apr 3, 2026	34.65	36.86	39.11

NVO shares rose +1.36% in Thursday, April 2, 2026's trading session, rising from a previous close of $36.48 to move at $36.98. The stock demonstrated notable intraday movement (see NVO's key stats for a full breakdown), fluctuating between $35.63 and $36.98, a +3.79% trading range. While recent weeks have seen some volatility, NVO has managed to secure a -0.28% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 14.56M shares changing hands, 9.43M fewer than the previous session. This amounted to $538.27M in total market activity.

Will NVO Continue Its Upward Trend?

According to analyst ratings and projections for NVO, Novo Nordisk A/S shares are anticipated to increase by +1.80%, potentially reaching $37.65 per share by April 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for NVO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the NVO stock forecast, now is a good time to buy NVO stock because its current trading price is +4.87% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NVO covering social and institutional perspectives.

NVO Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into NVO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.29% to 45.77%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.78%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.73%, maintains a neutral outlook for the long term. Insights into NVO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Novo Nordisk A/S Short-Term Forecasts

NVO Forecast For Next 5 Days

Our algorithm anticipates Novo Nordisk A/S (NVO) stock could hit $34.16 by Apr 10, 2026. This represents a -7.61% rise from today's price, following a +1.37% change over the past five days.

NVO Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Novo Nordisk A/S (NVO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $30.49, which would mean a -17.54% decrease from the current price of $36.98. Projections for this period range from a high of $39.88 to a low of $18.50.

NVO Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Novo Nordisk A/S's price over the next three months point to a drop. NVO stock is expected to peak at $49.71 on Apr 10, 2026 before potentially dipping to $15.14 on Jun 17, 2026. On average, NVO is likely to trade around $31.01 in the coming 90 days.

Novo Nordisk A/S Stock Forecast 2025

Based on our predictive models, Novo Nordisk A/S (NVO) is expected to trade between $8.39 and $49.71 throughout 2026. This would result in an average price of $27.65, potentially offering investors a -25.22% return from current levels.

Novo Nordisk A/S Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Novo Nordisk A/S (NVO) is positioned to show a strong performance in April 2026. The price is predicted to move between $23.81 and $49.71, settling at an average of $36.45. This could translate to a -1.42% loss.

May 2026

Based on current market signals, Novo Nordisk A/S is projected to trend may 2026. We forecast a trading range from $15.44 to $44.28, with a likely average price of $29.56. Investors could expect a potential return of -20.05%.

June 2026

Our predictive algorithms indicate Novo Nordisk A/S stock may see a shift in June 2026. The expected range spans $15.14–$41.87, with an average target of $28.11. This represents a cautious outlook and a possible loss of -23.98%.

July 2026

Analyzing established trends, Novo Nordisk A/S looks set to move in July 2026. Projections place the stock between $14.58 and $43.74, averaging around $28.68. This suggests a -22.43% loss from current levels.

August 2026

Market indicators suggest Novo Nordisk A/S could experience notable changes during August 2026. Prices could fluctuate within $15.05 to $42.63, with a midpoint forecast of $27.80. The stock might deliver a -24.81% loss.

September 2026

Forecasting for September 2026, models estimate that Novo Nordisk A/S may undergo key fluctuations. If trends hold, the stock might trade between $17.24 and $43.21, averaging $30.41. This signals a cautious trajectory with potential returns around -17.76%.

October 2026

According to our latest forecast models, Novo Nordisk A/S (NVO) is positioned to show a strong performance in October 2026. The price is predicted to move between $9.61 and $37.43, settling at an average of $23.39. This could translate to a -36.74% loss.

November 2026

Based on current market signals, Novo Nordisk A/S is projected to trend november 2026. We forecast a trading range from $8.39 to $35.42, with a likely average price of $22.46. Investors could expect a potential return of -39.26%.

December 2026

Our predictive algorithms indicate Novo Nordisk A/S stock may see a shift in December 2026. The expected range spans $9.06–$36.75, with an average target of $23.22. This represents a cautious outlook and a possible loss of -37.20%.

January 2027

Analyzing established trends, Novo Nordisk A/S looks set to move in January 2027. Projections place the stock between $8.96 and $37.06, averaging around $21.96. This suggests a -40.61% loss from current levels.

February 2027

Market indicators suggest Novo Nordisk A/S could experience notable changes during February 2027. Prices could fluctuate within $11.94 to $38.65, with a midpoint forecast of $24.59. The stock might deliver a -33.50% loss.

March 2027

Forecasting for March 2027, models estimate that Novo Nordisk A/S may undergo key fluctuations. If trends hold, the stock might trade between $2.02 and $30.42, averaging $17.37. This signals a cautious trajectory with potential returns around -53.02%.

April 2027

According to our latest forecast models, Novo Nordisk A/S (NVO) is positioned to show a strong performance in April 2027. The price is predicted to move between $6.01 and $28.11, settling at an average of $16.82. This could translate to a -54.51% loss.

NVO's history of dividends and stock splits also plays a role in long-term investor confidence.